ended4월 27일· 1 sources
코스맥스엔비티, 종속회사 해산 결정…출자금 52억
Why it matters
Cosmax NBT's decision to dissolve its subsidiary Dr. DNA signifies a strategic move towards corporate restructuring and capital efficiency. By liquidating an entity accounting for over 10% of its equity, the company aims to streamline operations and recover residual assets to strengthen its financial stability.
1
Sources
+0
24h
—
Growth
147d
Active
Cosmax NBTDr. DNAcorporate dissolutionbusiness restructuringliquidationhealth functional food